Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
English
עברית
العربية
Home
Profiles
Research units
Research output
Prizes
Activities
Search by expertise, name or affiliation
Motherisk update: Cancer chemotherapy during pregnancy
M. Lishner, G. Koren
Adelson School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Motherisk update: Cancer chemotherapy during pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Motherisk
100%
Chemotherapy
100%
Second Trimester
100%
Cancer Chemotherapy
100%
Major Malformations
100%
Chemotherapy in Pregnancy
100%
First Trimester
50%
Fetus
50%
Third Trimester
50%
Pregnant Women
50%
Low Birth Weight
50%
Pregnancy Trimester
50%
Chemotherapy-induced
50%
Oncologists
50%
Hodgkin Disease
50%
Medicine and Dentistry
First Trimester Pregnancy
100%
Congenital Malformation
100%
Motherisk
100%
Second Trimester Pregnancy
100%
Cancer Chemotherapy
100%
Low Birth Weight
50%
Third Trimester Pregnancy
50%
Oncologist
50%
Hodgkin's Lymphoma
50%
Nursing and Health Professions
Congenital Malformation
100%
Cancer Chemotherapy
100%
Low Birth Weight
50%
Oncologist
50%
Hodgkin Disease
50%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Cancer Chemotherapy
100%
Congenital Malformation
66%
Low Birth Weight
33%
Hodgkin Disease
33%
Biochemistry, Genetics and Molecular Biology
First Trimester Pregnancy
100%
Second Trimester Pregnancy
100%
Low Birth Weight
50%
Third Trimester Pregnancy
50%